Visual Abstract: Single vs Multidose Prophylactic IV Antibiotics in Implant-Based Breast Reconstruction

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 16, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31583?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091622

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Jessica Gahm, M.D., Ph.D., of Karolinska University Hospital in Stockholm, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.31583)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Self-Cut vs Mesh-Kit Polypropylene Mesh for Treatment of Pelvic Organ Prolapse

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 16, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31869?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091622

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Lan Zhu, M.D., of the National Clinical Research Center for Obstetric and Gynecologic Diseases in Beijing, and Xin Sun, Ph.D., of Sichuan University in Chengdu, China, are the corresponding authors.

(doi:10.1001/jamanetworkopen.2022.31869)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Medicare Advantage Financing, Quality in Puerto Rico vs US States, Washington, DC

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3073?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091622

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Estimated No Surprises Act Qualifying Payment Amounts vs Payments to Emergency Medicine Professionals

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3085?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091622

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Prevalence, Risk Factors for Medical Debt, Subsequent Changes in Social Determinants of Health

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 16, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31898?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091622

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The results of this analysis of survey data suggest that medical indebtedness is common, even among the insured, and may be associated with subsequent worsening of social determinants of health, such as the inability to pay rent, mortgage or utilities, eviction or foreclosure, and food insecurity.

Authors: David U. Himmelstein, M.D., of the City University of New York, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.31898)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Social Risk Factors With Mortality Among Adults With New Cancer Diagnosis

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 16, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.33009?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091622

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers examined the associations of multiple social risk factors, including financial hardship, food insecurity, housing instability and transportation difficulties, with mortality risk among patients newly diagnosed with cancer in the United States.

Authors: Matthew P. Banegas, Ph.D., of the University of California, San Diego, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.33009)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Out-of-State Telemedicine Visits Among Medicare Patients During Pandemic

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 16, 2022

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3013?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091622

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: In this study of telemedicine visits in the first half of 2021 among patients with Medicare, 422,000 patients had an out-of-state telemedicine visit, and they were most common among those who lived near a state border and were largely for primary care and mental health treatment. Early in the pandemic, in an effort to ensure access to care, states implemented temporary changes allowing physicians without a license in their state to provide care to their residents. There is debate on whether to change licensing rules permanently to facilitate out-of-state telemedicine use.

Authors: Ateev Mehrotra, M.D., of Harvard Medical School in Boston, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.3013)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effect of Total Intravenous Anesthesia on Pulmonary Complications in Microvascular Reconstruction for Head and Neck Cancer

JAMA Otolaryngology–Head & Neck Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 15, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2022.2552?guestAccessKey=7f2fb8d5-e6ff-4fad-81cd-46f9c88898c3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091522

 

Visual Abstract

Authors: Ching-Hui Shen, M.D., Ph.D., of Taichung Veterans General Hospital in Taichung, Taiwan, is the corresponding author.

 (doi:10.1001/jamaoto.2022.2552)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Monitor-Observed Therapy With Digital Event Reminder vs Directly Observed Therapy in Patients With Tuberculosis

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 15, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30509?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091522

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Tsegahun Manyazewal, Ph.D., of Addis Ababa University in Addis Ababa, Ethiopia, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.30509)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Race, Ethnicity, Socioeconomic Status With Visual Impairment in Adolescent Children

JAMA Ophthalmology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 15, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2022.3627?guestAccessKey=e8fe7302-2701-4c5b-bc79-e79fc927e51c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091522

 

About The Study: Adolescent children (ages 12 to 18 years) who identify as Black, Mexican American, low-income, or as a non-U.S. citizen were more likely to report poor subjective visual function and perform worse on objective visual acuity testing, suggesting that racial, ethnic, and socioeconomic disparities in visual function are evident by adolescence in the United States.

Authors: Isdin Oke, M.D., of Boston Children’s Hospital, Harvard Medical School in Boston, is the corresponding author.

 

(doi:10.1001/jamaophthalmol.2022.3627)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Durability of Immune Response After COVID-19 Booster Vaccination

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 15, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31778?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091522

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Reduction in antibody levels five months after the third BioNTech/Pfizer COVID-19 vaccine dose among nearly 4,000 health care workers in Israel was slower than after the second, while Omicron’s neutralizing response was lower compared with other variants of concern. Peak antibody levels after the third dose were associated with Omicron infection.

Authors: Mayan Gilboa, M.D., of the Sheba Medical Center in Ramat Gan, Israel, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.31778)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Analysis of School-Level Vaccination Rates in New York City

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 15, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31849?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091522

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers report differences in COVID-19 vaccination rates by race and ethnicity and geography in New York City schools.

Authors: Brian Elbel, Ph.D., M.P.H., of the New York University Grossman School of Medicine in New York, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.31849)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 14, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30367?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091422

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Isabella Heuser, M.D., Ph.D., of Charite – Universitatsmedizin Berlin, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.30367)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effect of Different Itraconazole Dosing Regimens in Adult Patients With Tinea Corporis/Cruris

JAMA Dermatology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 14, 2022

Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.3745?guestAccessKey=878fc873-61f2-4c27-9fee-12bd7754316a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091422

 

Visual Abstract

Authors: Ananta Khurana, M.D., of the Dr. Ram Manohar Lohia Hospital and Atal Bihari Vajpayee Institute of Medical Sciences in New Delhi, is the corresponding author.

(doi:10.1001/jamadermatol.2022.3745)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Illness Experiences, Psychosocial Outcomes for Reservation-Area American Indian Youth During COVID-19

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 14, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31764?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091422

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers assessed in this survey study of 2,500 reservation-area American Indian youth self-reported illness experiences and changes in psychosocial factors during the COVID-19 pandemic.

Authors: Linda R. Stanley, Ph.D., of Colorado State University in Fort Collins, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.31764)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Risk Factors for Conversion From a COVID-19 Household Contact to a Case in New York

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 14, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.33001?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091422

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Data from more than 600,000 household contacts in New York City were analyzed to characterize the risks of acquiring SARS-CoV-2 infection after household exposure.

Authors: Katherine Whittemore, M.P.H., of New York City Health and Hospitals in New York, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.33001)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: In-Person vs Video Training, Full vs Limited Function in Portal Use Among Inpatients

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 13, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31321?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091322

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Ann Scheck McAlearney, Sc.D., M.S., of Ohio State University in Columbus, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.31321)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Persistence, Protective Potential of SARS-CoV-2 Antibody Levels After COVID-19 Vaccination

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 13, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31334?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091322

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers assessed SARS-CoV-2 spike antibody levels and their association with subsequent infection among 2,100 West Virginia nursing home residents and staff who had previously received SARS-CoV-2 vaccination.

Authors: Sally Hodder, M.D., of the West Virginia University School of Medicine in Morgantown, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.31334)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effects of Real-time Prescription Benefit Recommendations on Out-of-Pocket Costs

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 12, 2022

Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3946?guestAccessKey=82eaf621-fbb1-4def-bc3a-30ce791b5274&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091222

 

Visual Abstract

Authors: Sunita M. Desai, Ph.D., of the NYU Grossman School of Medicine in New York, is the corresponding author.

(doi:10.1001/jamainternmed.2022.3946)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology, Clinical Outcomes

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 12, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.2793?guestAccessKey=4d5bb88d-c490-457c-920e-3aa86ab39f37&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091222

 

Visual Abstract

Authors: John R. Sims, M.D., of Eli Lilly and Company in Indianapolis, is the corresponding author.

(doi:10.1001/jamaneurol.2022.2793)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effect of Diabetes Prevention Program Among Latino Youths With Prediabetes

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, SEPTEMBER 12, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.31196?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091222

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Gabriel Q. Shaibi, Ph.D., of Arizona State University in Phoenix, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.31196)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

USPSTF Statement on Screening for Type 2 Diabetes in Children, Adolescents

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 13, 2022

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14543?guestAccessKey=20b7ea1e-0bf0-40b1-9558-6f9566dde67e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091322

 

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to make a recommendation about screening for type 2 diabetes in asymptomatic children and adolescents younger than age 18. The Centers for Disease Control and Prevention estimates that as of 2018 approximately 23,000 children and adolescents had type 2 diabetes, and data indicate that the incidence is rising. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and has not previously released a recommendation on this topic.

 

(doi:10.1001/jama.2022.14543)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Comparison of Low-Value Services Among Medicare Advantage, Traditional Medicare Beneficiaries

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 9, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2935?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090922

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: Medicare beneficiaries enrolled in Medicare Advantage had lower rates of low-value care (tests, treatments, and procedures that provide little to no clinical benefit) than those enrolled in traditional Medicare in this study of 2.4 million Medicare beneficiaries.

Authors: Brian W. Powers, M.D., M.B.A., of the Tufts University School of Medicine in Boston, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.2935)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Analysis of Gestational Weight Gain During Pandemic

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 9, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30954?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090922

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The study suggests that the COVID-19 pandemic was associated with higher gestational weight gain (GWG) and higher risk of excessive GWG among individuals pregnant with one child, especially those individuals younger than 25 years, non-Hispanic Black individuals, unmarried individuals, individuals with obesity before pregnancy, and individuals with Medicaid to pay for delivery.

Authors: Shengzhi Sun, Ph.D., of Capital Medical University in Beijing, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.30954)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association Between Medicaid Dental Payment Policies, Children’s Dental Visits

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 9, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3041?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090922

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: Increased Medicaid dental payment rates were associated with significant but modest improvements in children’s dental visits and oral health according to this analysis of nationally representative survey data.

Authors: Brandy J. Lipton, Ph.D., of San Diego State University in San Diego, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.3041)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

COVID-19-Associated Hospitalizations Among Vaccinated, Unvaccinated Adults

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 8, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.4299?guestAccessKey=3faf8cc0-3718-4b07-a5eb-fc81fa410537&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090822

 

About The Study: When Omicron was the dominant variant during the early months of 2022 from January to April, COVID-19-associated hospitalization rates were 10.5 times higher in unvaccinated adults and 2.5 times higher in vaccinated adults with no booster dose compared with those who had received a booster dose. Results of the study suggest that clinicians and public health practitioners should continue to promote vaccination with all recommended doses for eligible persons.

Authors: Fiona Havers, M.D., M.H.S., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.

 

(doi:10.1001/jamainternmed.2022.4299)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Analysis of Vaccine Reactions After Booster Doses Among Pregnant, Lactating Individuals

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 8, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30495?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090822

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The findings of this study with 17,000 participants suggest that COVID-19 boosters or third doses were well tolerated by individuals who were pregnant and lactating. Data on COVID-19 vaccine boosters are particularly important as vaccine uptake during pregnancy is lagging, and strategies to reduce hesitancy, increase acceptance, and help guide discussions between pregnant and lactating persons and maternal care professionals are needed.

Authors: Alisa Kachikis, M.D., M.S., of the University of Washington in Seattle, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.30495)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Characteristics of Patients With Long COVID, Persistent Impaired Sense of Smell

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 8, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30637?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090822

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this study of 219 patients with long COVID and neurologic symptoms, 64% had an impaired sense of smell, with the highest prevalence among women, adults, and those not hospitalized during the acute phase of COVID-19. Patients with an impaired sense of smell may develop severe loss of smell that may persist for more than 1 year after the onset of symptoms.

Authors: Luiz Fabio Magno Falcao, Ph.D., of Para State University in Belem, Brazil, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.30637)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Artificial Pancreas vs Current Diabetes Care After Total Pancreatectomy

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 7, 2022

Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.3702?guestAccessKey=96d90596-4002-4bc4-b9da-ec3c00c8894d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090722

 

Visual Abstract

Authors: Marc G. Besselink, M.D., Ph.D., of the University of Amsterdam, is the corresponding author.

(doi:10.1001/jamasurg.2022.3702)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Psychological Distress Prior to Infection With Risk of Post–COVID-19 Conditions

JAMA Psychiatry

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 7, 2022

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.2640?guestAccessKey=4e438d50-c1ee-4fd6-ba40-0ab9ee8c45e6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090722

  

About The Study: In this study of individuals followed up for more a year starting in April 2020, researchers found pre-infection psychological distress, including symptoms of depression, anxiety, worry about COVID-19, loneliness, and perceived stress, was strongly associated with the risk of post–COVID-19 conditions, sometimes called long COVID, among those infected with SARS-CoV-2.

Authors: Siwen Wang, M.D., of the Harvard T.H. Chan School of Medicine in Boston, is the corresponding author.

 

(10.1001/jamapsychiatry.2022.2640)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Comparison of COVID-19 Rates Among In-Person, Virtual Attendees of a Large Professional Society Meeting

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, SEPTEMBER 7, 2022

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30300?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090722

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This survey study found that although most registrants of a large professional society meeting held during the Omicron surge attended the meeting in person, rates of COVID-19 positivity were low and equivalent among in-person and virtual attendees. Conference organizers adapted planned safety measures to account for increased variant transmissibility and case numbers. These data suggest that among highly vaccinated clinicians with high risk of occupational exposure, cautious strategies to mitigate COVID-19 transmission during a surge were effective, and in-person meeting attendance posed no greater risk than professional hazards.

Authors: Callisia N. Clarke, M.D., M.S., of the Medical College of Wisconsin in Milwaukee, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.30300)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effect of Clinical Decision Support With Audit, Feedback on Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 6, 2022

Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13382?guestAccessKey=d894e242-8fec-4686-b852-5d66759380b2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090622

 

Visual Abstract

Authors: Matthew T. James, M.D., Ph.D., of the University of Calgary in Calgary, Canada, is the corresponding author.

(doi:10.1001/jama.2022.13382)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effect of Individualized Audit, Feedback Intervention on Rates of Musculoskeletal Diagnostic Imaging Requests by General Practitioners

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 6, 2022

Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14587?guestAccessKey=72675e6a-e4f4-40f1-8e23-198e49c91fe6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090622

 

Visual Abstract

Authors: Denise A. O’Connor, Ph.D., of Monash University in Melbourne, Australia, is the corresponding author.

(doi:10.1001/jama.2022.14587)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Orphanhood, Caregiver Loss Among Children Based on Global Excess COVID-19 Death Estimates

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 6, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.3157?guestAccessKey=062be887-7f22-4229-9d6b-0f97ff4523fa&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090622

 

About The Study: Using World Health Organization excess mortality data, researchers estimate that 10.5 million children lost parents or caregivers and 7.5 million children experienced COVID-19–associated orphanhood through May 1, 2022.

Authors: Joel-Pascal Ntwali N’konzi, M.Sc., of the African Institute for Mathematical Sciences in Kigali, Rwanda, and Susan Hillis, Ph.D., of the University of Oxford in Oxford, United Kingdom, are the corresponding authors.

 

(doi:10.1001/jamapediatrics.2022.3157)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Insurance Mix, Diagnostic Coding Practices in New York State Hospitals

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2919?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090222

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Comparing Diagnoses From Video Telemedicine With In-Person Visits

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 2, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.29958?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090222

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this study of nearly 2,400 patients who underwent a video telemedicine consultation followed by an in-person outpatient visit for the same clinical problem in the same specialty within a 90-day window, the provisional diagnosis established over video telemedicine visit matched the in-person reference standard diagnosis in 87% of cases. These findings suggest that video telemedicine visits yield a high degree of diagnostic concordance to in-person visits for most new clinical concerns.

Authors: Bart M. Demaerschalk, M.D., M.Sc., of the Mayo Clinic College of Medicine and Science in Phoenix, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.29958)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Private Equity Acquisition of Physician Practices With Changes in Health Care Spending, Use

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 2, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2886?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090222

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: The findings of this study suggest that among a large commercially insured population, private equity acquisitions of 578 dermatology, gastroenterology, and ophthalmology physician practices were associated with increased health care spending and several measures of utilization.

Authors: Jane M. Zhu, M.D., M.P.P., M.S.H.P., of Oregon Health & Science University in Portland, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.2886)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Patient Demographic Characteristics, Devices Used to Access Telehealth Visits

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, SEPTEMBER 2, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2932?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090222

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: This analysis of data from a large primary care network found that telephones and tablets were used for most telehealth visits, and higher rates of telephone or tablet use were seen among patients who were younger, Black or Hispanic or Latino, and living in lower-income zip codes. These results may help inform efforts to increase access to telehealth.

Authors: Eric Bressman, M.D., M.S.H.P., of the University of Pennsylvania in Philadelphia, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.2932)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Efficacy, Safety of Telaglenastat Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 1, 2022

Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3511?guestAccessKey=c6ad7a6b-caf2-411c-a706-d6e65b18d0c6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090122

 

Visual Abstract

Authors: Nizar M. Tannir, M.D., of the University of Texas MD Anderson Cancer Center in Houston, is the corresponding author.

(doi:10.1001/jamaoncol.2022.3511)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 1, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3829?guestAccessKey=efae0fdc-ee29-440a-bcb1-3851ebb46e11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090122

 

Visual Abstract

Authors: Thierry Conroy, M.D., of the Institut de Cancérologie de Lorraine in Vandoeuvre-lès-Nancy, France, is the corresponding author.

(doi:10.1001/jamaoncol.2022.3829)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Telehealth Services, Medications for Opioid Use Disorder, Overdose Among Medicare Beneficiaries Before, During COVID-19

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.2284?guestAccessKey=ee7219e9-7be8-4f85-bf27-6313250cfea3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=083122

Genetic Spectrum of Uncombable Hair Syndrome

JAMA Dermatology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 31, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.2319?guestAccessKey=26fe63b7-c8fa-41f1-b2f2-65fba9448ac2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=083122

 

About The Study: Researchers conducted a genetic analysis of individuals with uncombable hair syndrome, a rare hair shaft anomaly that is characterized by dry, frizzy and wiry hair that cannot be combed flat. Only about 100 known cases have been reported so far.

Authors: Regina C. Betz, M.D., of the University of Bonn in Bonn, Germany, is the corresponding author.

 

(doi:10.1001/jamadermatol.2022.2319)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Maternal Mental Health, Infant Development During Pandemic

JAMA Psychiatry

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 31, 2022

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.2591?guestAccessKey=ee24b3f1-a54f-420d-be90-5ebf0b7e039e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=083122

  

About The Study: This article provides an overview of the current understanding of associations between the COVID-19 pandemic and mental health among pregnant and postpartum women and infant behavioral development.

Authors: Catherine Monk, Ph.D., of Columbia University in New York, is the corresponding author.

 

(10.1001/jamapsychiatry.2022.2591)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Clinical, Virological Characteristics of SARS-CoV-2 Infection in Young Children

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 31, 2022

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27348?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083122

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this study involving 690 participants from 175 households, SARS-CoV-2 infections were frequently asymptomatic in children age 4 and younger. The presence and number of symptoms did not correlate with viral load. These findings suggest that symptom screening may be insufficient to prevent outbreaks involving young children.

Authors: Ruth A. Karron, M.D., of Johns Hopkins University in Baltimore, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.27348)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effects of Exercise Program on Brain Health Outcomes for Children With Overweight or Obesity

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 30, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27893?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083022

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Francisco B. Ortega, Ph.D., of the University of Granada in Granada, Spain, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.27893)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Abusive Head Trauma in Infants During COVID-19 in Paris Metropolitan Area

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 30, 2022

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.26182?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083022

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers found a marked increase in the incidence and severity of abusive head trauma in infants during the COVID-19 pandemic period in the Paris metropolitan area compared with the pre-pandemic period. Although the containment and mitigation measures were necessary to reduce the spread of COVID-19, they may have had unintended health consequences for children, such as an increase in abusive head trauma. These results suggest the need for clinical awareness and preventive actions.

Authors: Flora Blangis, M.P.H., of the Universite Paris Cite in Paris, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.26182)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Domestic Violence Consultations in Japan Before vs During Pandemic

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 30, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.29421?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=083022

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This study found that rates of help-seeking consultations for domestic violence increased during the COVID-19 pandemic in Japan. This increase may be associated with a range of factors, including economic instability, increased exposure to exploitative relationships, and reduced support options.

Authors: Xerxes T. Seposo, Ph.D., M.P.H., of Hokkaido University in Sapporo, Japan, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.29421)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Efficacy, Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.2480?guestAccessKey=9ed5d243-d7ec-43eb-9df6-d95d4b6e1c69&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082922

 

Visual Abstract

Authors: Eric P. Hoffman, Ph.D., of School of Pharmacy and Pharmaceutical Sciences Binghamton University—State University of New York in Binghamton, is the corresponding author.

(doi:10.1001/jamaneurol.2022.2480)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Improving Antibiotic Stewardship for Diarrheal Disease With Probability-Based Electronic Clinical Decision Support

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.2535?guestAccessKey=9ef9098c-a014-470b-9b24-fe8938b82ed9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082922

 

Visual Abstract

Authors: Eric J. Nelson, M.D., Ph.D., of the University of Florida in Gainesville, and Daniel T. Leung, M.D., M.Sc., of the University of Utah School of Medicine in Salt Lake City, are the corresponding authors.

(doi:10.1001/jamapediatrics.2022.2535)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Comparison of SARS-CoV-2 Results in Self-Collected vs Health Care Worker–Collected Nasal Swabs in Children, Adolescents

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14877?guestAccessKey=d98d9357-ab4b-477a-b97c-ae5c9382870c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082622

 

About The Study: After hearing and seeing simple instructional materials, children and adolescents ages 4 to 14 self-collected nasal swabs that closely agreed on SARS-CoV-2 detection with swabs collected by health care workers.

Authors: Wilbur A. Lam, M.D., Ph.D., and Greg S. Martin, M.D., M.Sc., of the Emory University School of Medicine in Atlanta, are the corresponding authors.

 

(doi:10.1001/jama.2022.14877)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Analysis of Neutralizing Antibody Levels in Children, Adolescents After SARS-CoV-2 Infection

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.3072?guestAccessKey=9d515e08-5df1-4b6e-ab4a-9b947b1d429c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082922

 

About The Study: This study assessed the presence of neutralizing antibodies in blood samples of children in different age groups up to 16 months after SARS-CoV-2 infection.

Authors: Chee Fu Yung, M.B.Ch.B., of the KK Women’s and Children’s Hospital in Singapore, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2022.3072)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Pandemic With Medical School Diversity Programs

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.29086?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082922

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The findings of this survey study suggest that medical school programs designed to increase the diversity of the physician workforce were disrupted by the COVID-19 pandemic. The long-term outcomes of these disruptions are unknown.

Authors: Sonal Batra, M.D., M.S.T., of George Washington University in Washington, D.C., is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.29086)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Administration of Anti–SARS-CoV-2 Monoclonal Antibodies After FDA Deauthorization

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 29, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28997?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082922

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Hospitals and health systems administered more than 158,000 anti–SARS-CoV-2 monoclonal antibodies (mAbs) doses in early 2022 despite Food and Drug Administration (FDA) deauthorization because of a lack of efficacy against the Omicron variant. Medicare payments for mAb administration range from $450 to $750 per dose, indicating that spending on these deauthorized treatments likely exceeds $71 million. The findings suggest that the use of deauthorized mAb products was widespread, even though patients had a minimal likelihood of benefit.

Authors: Timothy S. Anderson, M.D., M.A.S., of Beth Israel Deaconess Medical Center in Boston, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.28997)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Use of Digital Platform to Report COVID-19 Self-Test Results to Health Departments

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28885?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082622

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The results of this study of 14,000 household beneficiaries of a COVID-19 test kit program in six communities suggest that application-based reporting with incentives may be associated with increased reporting of rapid tests for COVID-19. However, increasing its use may be a critical first step.

Authors: Apurv Soni, M.D., Ph.D., of the University of Massachusetts Chan Medical School in Worcester, is the corresponding author.

 

 (doi:10.1001/jamanetworkopen.2022.28885)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

COVID-19 Incidence, Severity Among Adults Vaccinated With, Without Boosters in Singapore

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28900?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082622

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This study of 2.4 million adults in Singapore investigated levels of protection against severe COVID-19 and confirmed SARS-CoV-2 infection across several vaccine types, vaccine combinations and time since last dose.

Authors: Oon Tek Ng, M.R.C.P., of the National Centre for Infectious Diseases in Singapore, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.28900)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association Between Medicaid Managed Care Coverage of Substance Use Services, Treatment Use

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2812?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082622

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: Researchers examined the association between changes in Medicaid managed care coverage of substance use services and admissions for substance use treatment in Maryland and Nebraska from 2010 to 2019.

Authors: Samantha G. Auty, M.S., of the Boston University School of Public Health, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.2812)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Medicare Advantage Premiums With Measures of Quality, Patient Experience

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 26, 2022

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2826?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082622

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: The findings of this analysis suggest that although there were modest improvements in the average quality of care offered by high-premium Medicare Advantage plans, plans with high quality of care are available at every premium level.

Authors: Marc N. Elliott, Ph.D., of the RAND Corporation in Santa Monica, California, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.2826)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of COVID-19 Infection With Wearing Glasses in a High-Prevalence Area in Denmark and Sweden

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2022.3234?guestAccessKey=7d56433d-f458-4ca2-b4f1-97804445be00&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522

Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3677?guestAccessKey=14d8ef3b-d59d-4322-aee4-d8ef1be7480d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522

Missed Opportunities and Health Disparities for Advance Care Planning Before Elective Surgery in Older Adults

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.3687?guestAccessKey=1c53c68b-501a-40bf-95fc-9a885c656de1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082422

Association Between Geospatial Access to Care and Firearm Injury Mortality in Philadelphia

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.3677?guestAccessKey=66837b8e-24f0-457f-965f-7cca4bcc77f8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082422

Reporting of Race and Hispanic Ethnicity in Breast Cancer Studies From the National Cancer Database

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3527?guestAccessKey=df819b8f-2bea-41e3-a44d-a56c120be434&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.2096?guestAccessKey=e1328a7a-6e79-43f8-ad04-143fd8134839&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082422

Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28500?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082322

Visual Abstract: Effect of Azithromycin Treatment to Preschool-Age Children on Trachoma Prevalence in Niger

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 23, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28244?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082322

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Jeremy D. Keenan, M.D., M.P.H., of the University of California, San Francisco, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.28244)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Replacement

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 23, 2022

Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13416?guestAccessKey=62ec1f84-1cf8-4fc2-b40e-dae49589eb3b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082322

 

Visual Abstract

Authors: Verinder S. Sidhu, M.S., of the Ingham Institute for Applied Medical Research in Liverpool, Australia, is the corresponding author.

(doi:10.1001/jama.2022.13416)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Radiotherapy With vs Without Chemoradiotherapy, Survival Without Disease Relapse in Low-risk Nasopharyngeal Carcinoma

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 23, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13997?guestAccessKey=dce288b8-286c-4062-8bd6-49206e468806&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082322

 

Visual Abstract

Authors: Jun Ma, M.D., of Sun Yat-sen University Cancer Center in Guangzhou, China, is the corresponding author.

(doi:10.1001/jama.2022.13997)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

COVID-19 Disease Severity With Omicron Sublineages, Vaccination Status

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3351?guestAccessKey=c3d7dbab-fe64-4d08-bd10-cd1d421972c9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222

Association of Fatal Overdose Notification Letters With Prescription of Benzodiazepines

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3372?guestAccessKey=e837f041-62d7-4699-b157-c572ad69312c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222

Long-term Outcomes of Childhood Family Income Supplements on Adult Functioning

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.2946?guestAccessKey=c9f1ed42-ba06-4ed3-afe0-53e814d9d215&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222

USPSTF Recommendation on Statin Use for Primary Prevention of Cardiovascular Disease

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, AUGUST 23, 2022

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13044?guestAccessKey=1abe13bf-c396-4e82-b61e-cc0aa85cdd49&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082322

 

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends that for primary prevention of cardiovascular disease (CVD) in adults ages 40 to 75 who have one or more CVD risk factors (i.e., dyslipidemia, diabetes, hypertension, or smoking), clinicians should prescribe a statin for those with an estimated 10-year CVD risk of 10% or greater and selectively offer a statin for those with an estimated risk of 7.5% to less than 10%. The USPSTF concludes that the current evidence is insufficient to make a recommendation about initiating a statin for the primary prevention of CVD events and mortality in adults age 76 or older. Cardiovascular disease is the leading cause of death in the United States, the cause of more than 1 of every 4 deaths. The USPSTF routinely makes recommendations about the effectiveness of preventive care services, and this recommendation replaces and is generally consistent with its 2016 recommendation.

 

(doi:10.1001/jama.2022.13044)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Examining Association of Chronic Disease With Financial Outcomes of Patients

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 22, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.3687?guestAccessKey=f5ca82da-d842-428d-8e13-4e3a431f54af&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222

 

About The Study: This study of 2.8 million commercially insured adults found an association between chronic disease diagnoses and adverse credit report outcomes, with increasing rates of medical debt in collections, nonmedical debt in collections, total delinquent debt, low credit score and recent bankruptcy as an individual’s number of chronic conditions increased.

Authors: Nora V. Becker, M.D., Ph.D., of the University of Michigan in Ann Arbor, is the corresponding author.

 

(doi:10.1001/jamainternmed.2022.3687)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Symptoms, Health Conditions in Children Following SARS-CoV-2 Infection

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 22, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.2800?guestAccessKey=f8454215-bfaa-487e-b4e4-5f0a3f8405c9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082222

 

About The Study: This study of nearly 660,000 children who were tested for SARS-CoV-2 by antigen or polymerase chain reaction examined the symptoms, diagnosed health conditions and medications associated with SARS-CoV-2 infection four weeks or more following the initial test.

Authors: Suchitra Rao, M.B.B.S., M.S.C.S., of the University of Colorado School of Medicine and Children’s Hospital Colorado in Aurora, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2022.2800)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Incubation Period of COVID-19 Caused by Different SARS-CoV-2 Strains

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, AUGUST 22, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.28008?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=082222

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The findings of this systematic review and meta-analysis of 141 articles suggest that with the evolution of mutant strains, the incubation period of COVID-19 decreased gradually from Alpha (5 days) to Omicron variant (3.42 days). Identifying the incubation period of different variants is a key factor in determining the isolation period.

Authors: Min Liu, Ph.D., of Peking University in Beijing, and Wannian Liang, Ph.D., of Tsinghua University in Beijing, are the corresponding authors.

 

(doi:10.1001/jamanetworkopen.2022.28008)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Therapeutic Value of Drugs Granted Accelerated Approval or Conditional Marketing Authorization

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2685?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081922

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated Adults

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 19, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.27680?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081922

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this survey study of 135,000 adults, less than half (48.5%) of individuals who had been fully vaccinated nationwide had received a booster dose. Marked variations were seen across geographic locations, occupation types, and other sociodemographic characteristics. Targeted efforts at populations with low uptake may be needed to improve booster vaccine coverage.

Authors: Israel T. Agaku D.M.D., M.P.H., M.B.A., Ph.D., of NYC Health + Hospitals in New York, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.27680)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Out-of-Pocket Costs for Naloxone

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 19, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2663?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081922

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: In this observational study of nearly 720,000 pharmacy claims data, out-of-pocket cost of naloxone had been an increasingly substantial barrier to naloxone access for uninsured patients, potentially limiting use among this population, which constituted approximately 20% of adults with opioid use disorder.

Authors: Evan D. Peet, Ph.D., of the RAND Corporation in Pittsburgh, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.2663)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Comparing Prevalence of HPV Infection

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, AUGUST 19, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.2706?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=081922

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: Researchers compared the prevalence of human papillomavirus (HPV) among women born in the 1980s versus the 1990s and a pre-HPV vaccination period (2005-2006) versus a recent vaccination period (2015-2016).

Authors: Ashish A. Deshmukh, Ph.D., M.P.H., of the University of Texas Health Science Center School of Public Health in Houston, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.2706)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.